FIELD: chemistry.
SUBSTANCE: invention relates to 9-(quinonyl-2)-2-n-ethoxyphenylethyl-4,5,6,7,8,9,10,11-octahydropyrido[1,2-a] pyrazine-1,4-dione of formula I 
or pharmaceutically acceptable complex derivatives thereof. The invention also relates to use of the compound of formula I.
EFFECT: novel derivative which can be used as an antiulcer agent is obtained.
4 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR GASTRIC AND/OR DUODENAL ULCER | 2010 |
|
RU2448702C2 |
| MEDICINE WITH ANTI-ULCER ACTIVITY | 0 |
|
SU1831338A3 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
| METHOD FOR SELECTING DUODENAL PEPTIC ULCER TREATMENT TYPE | 2003 |
|
RU2252709C1 |
| COMPOSITION INHIBITING SECRETION OF ACID IN STOMACH | 2003 |
|
RU2340358C2 |
| 3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING RABEPRAZOLE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2554735C1 |
| ANNELATED PYRROL COMPOUNDS AS PROTONIC PUMP INHIBITORS FOR ULCER TREATMENT | 2003 |
|
RU2336872C2 |
| REGIME OF ADMINISTRATION OF INHIBITORS OF [H,K]-ATPASE | 1997 |
|
RU2203662C2 |
| PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
